Literature DB >> 1891493

Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation.

H Akamatsu1, J Komura, Y Asada, Y Niwa.   

Abstract

The effect of glycyrrhizin on inflammatory mediators such as neutrophil functions including reactive oxygen species (ROS) generation was examined. Glycyrrhizin significantly decreased neutrophil-generated O2-, H2O2 and OH in a dose-dependent manner. However, the drug did not reduce any of the ROS generated in a cell-free, xanthine-xanthine oxidase system. The drug did not affect neutrophil chemotaxis or phagocytosis, either. The present study indicates that glycyrrhizin is not an ROS scavenger but exerts an anti-inflammatory action by inhibiting the generation of ROS by neutrophils, the most potent inflammatory mediator at the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891493     DOI: 10.1055/s-2006-960045

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  25 in total

1.  Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents.

Authors:  P Thiyagarajan; C V Chandrasekaran; H B Deepak; Amit Agarwal
Journal:  Inflammopharmacology       Date:  2011-02-17       Impact factor: 4.473

2.  Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.

Authors:  Rosanna Di Paola; Marta Menegazzi; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Martina Dal Bosco; Zhenzhen Zou; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2008-10-25       Impact factor: 17.440

3.  PADMA-28, a traditional tibetan herbal preparation inhibits the respiratory burst in human neutrophils, the killing of epithelial cells by mixtures of oxidants and pro-inflammatory agonists and peroxidation of lipids.

Authors:  I Ginsburg; M Sadovnik; S Sallon; I Milo-Goldzweig; R Mechoulam; A Breuer; D Gibbs; J Varani; S Roberts; E Cleator; N Singh
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

4.  18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression.

Authors:  Danyelle R Long; Julia Mead; Jay M Hendricks; Michele E Hardy; Jovanka M Voyich
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 5.  A comprehensive review on pharmacotherapeutics of herbal bioenhancers.

Authors:  Ghanshyam B Dudhatra; Shailesh K Mody; Madhavi M Awale; Hitesh B Patel; Chirag M Modi; Avinash Kumar; Divyesh R Kamani; Bhavesh N Chauhan
Journal:  ScientificWorldJournal       Date:  2012-09-17

6.  Glycyrrhetic acid synergistically enhances β₂-adrenergic receptor-Gs signaling by changing the location of Gαs in lipid rafts.

Authors:  Qian Shi; Yuanyuan Hou; Jie Hou; Penwei Pan; Ze Liu; Min Jiang; Jie Gao; Gang Bai
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice.

Authors:  Xiao-Lan Li; Ai-Guo Zhou; Li Zhang; Wei-Jun Chen
Journal:  Int J Mol Sci       Date:  2011-01-26       Impact factor: 5.923

8.  Effects of a non-conservative sequence on the properties of β-glucuronidase from Aspergillus terreus Li-20.

Authors:  Yanli Liu; Jie Huangfu; Feng Qi; Imdad Kaleem; Wenwen E; Chun Li
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

9.  Cardioprotective effects of glycyrrhizic acid against isoproterenol-induced myocardial ischemia in rats.

Authors:  Nagaraja Haleagrahara; Julian Varkkey; Srikumar Chakravarthi
Journal:  Int J Mol Sci       Date:  2011-10-21       Impact factor: 5.923

10.  Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid.

Authors:  Wei Wang; Meng Luo; Yujie Fu; Song Wang; Thomas Efferth; Yuangang Zu
Journal:  Int J Nanomedicine       Date:  2013-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.